Compare Ross Stores, Inc. (ROST) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ross Stores, Inc. vs Zoetis Inc — how do they compare? Ross Stores, Inc. trades at $225.22 (market cap $73.25B), while Zoetis Inc trades at $73.65 (market cap $30.40B). The key difference: Ross Stores, Inc. is far larger — about 2.4× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.88%). Which is the better fit depends on your goals.
| ROST | ZTS | |
|---|---|---|
Market Cap | $73.25B | $30.40B |
Sector | Consumer Cyclical | Health |
52-Week High | $255.23 | $150.61 |
52-Week Low | $144.67 | $71.91 |
Enterprise Value | $73.70B | $37.96B |
Dividend Yield | 0.78% | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ross Stores (ROST) trades at $229.31, down 0.6% on the day, amid a bearish technical signal but strong fundamental performance. The company has consistently beaten earnings estimates, with Q2 2026 EPS of $2.66 surpassing the $1.95 forecast, and raised its full-year outlook. Revenue reached $21.13B in 2025, with net income of $2.09B and robust profitability metrics, including a 42.63% ROE. Analysts maintain a bullish consensus with a $271.33 price target, though technical indicators show near-term resistance.
The outlook for ROST is positive, driven by strong execution, expanding margins, and resilient consumer demand for value retail. Investment opportunities include continued earnings growth and potential upside to analyst targets. Key risks involve macroeconomic sensitivity, competitive pressures, and any deviation from its traffic growth trajectory. The stock's valuation at a P/E of 27.73 requires sustained performance to justify further gains.
Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.
The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
